Meet Pharmidex at KTN 2016
June 14, 2016

Collaboration opportunities in regenerative medicine

Pharmdiex will be attending the Innvoate UK KTN 2016 meeting focused on New Collaboration Opportunities in Regenerative Medicine.

The KTN in collaboration with Innovate UK, Cell and Gene Therapy Catapult, Department of Health and Kings College London are holding an event focussing on new unmet clinical needs, latest developments in regulatory environment and clinical adoption. Following recent developments and the UK’s Regenerative Medicine Expert Group report recommendations, this event will bring together the UK regenerative medicine communities involving industrialists, academics and clinicians from a number of clinical specialities.


The UK is leading the field in the development of cell and gene therapies. The regulatory system now has a number of mechanisms to accelerate the progress of promising therapies including EAMS and the proposed new PRIME scheme. However, practical challenges still exist to the clinical adoption of these new therapies and getting them to patients, including generating sufficient clinical data, achieving reimbursement and embedding therapies in existing or new clinical pathways).


Leading clinicians and experts from a number of organisations will be presenting at this event. Directors and managers from major funding organisations, e.g. Innovate UK, Research Councils, relevant charities will also be invited to support this event.


The main aims of this event are as follows;


  • To discuss challenges affecting clinical adoption of cell and gene-based therapies.
  • Facilitate new clinician/industry collaborations in a number of areas of clinical specialities.
  • Identify barriers to innovation and commercialisation.
  • Review current funding opportunities and identify funding gaps.
  • Provide networking opportunities to identify collaborating partners.
  • Review supporting mechanisms available to accelerate innovation and commercialisation through KTN and partners Innovate UK, Cell and Gene Therapy Catapult organisations.
  • Review current pre-clinical and clinical trials and identify best practice to accelerate regulatory approvals


For more information please see the following link: https://www.eventbrite.co.uk/e/new-collaboration-opportunities-in-regenerative-medicine-tickets-24454460951

January 5, 2026
We’re excited to expand our Bioanalytical team and are currently recruiting for two on-site, full-time roles supporting regulated and non-regulated programmes across small and large molecules: 1 - Technical Specialist, Bioanalysis (LC-MS) This is a senior technical authority role for an experienced LC-MS/MS scientist who enjoys solving complex analytical challenges and shaping technical direction. You’ll lead advanced method development and validation, support regulated studies, and mentor other scientists within a collaborative CRO environment. Ideal for candidates with: 5+ years of hands-on LC-MS/MS bioanalytical experience Strong expertise in method development, validation, and troubleshooting Experience with peptides, oligonucleotides, and large molecules Solid knowledge of GLP/GCP bioanalysis CRO experience (strongly preferred) 2 - Bioanalytical Scientist (Regulatory Studies) This role suits a hands-on bioanalytical scientist with experience delivering high-quality data for GLP/GCP studies. You’ll be involved across the full bioanalytical workflow, from method development to reporting, working closely with internal teams and (depending on experience) clients. Ideal for candidates with: A degree in Chemistry or a related discipline 5+ years’ experience in a bioanalytical laboratory Proven experience supporting GLP and/or GCP studies Strong LC-MS, sample preparation, and large-molecule expertise Experience with peptides and oligonucleotides โœจ Why Pharmidex? At Pharmidex, you’ll join a science-driven CRO where quality, accountability, and technical excellence matter. These roles offer real impact, strong collaboration, and the opportunity to contribute to diverse therapeutic programmes. ๐Ÿ“ฉ Interested? Please, check the full offers detail at https://www.pharmidex.com/careers-at-pharmidex and send your CV and a short cover note to [email protected] Feel free to share or tag anyone who might be a great fit!
December 31, 2025
As we step into 2026, we’re proud to continue supporting our clients with local UK expertise delivered at an international scale. At Pharmidex , we support programmes from discovery through to IND-enabling studies, helping teams progress confidently from concept to clinic. With integrated in vivo, bioanalysis and translational capabilities, everything is delivered under one roof in the UK, ensuring quality, continuity and efficiency at every stage. 2025 was one of the most challenging years our industry has faced, yet together we continued to deliver meaningful science, supporting nearly 1,000 projects and contributing to medicines that make a real difference to patients’ lives. Thank you to our clients and partners for your continued trust. We look forward to supporting innovation and high-quality science in the year ahead.
December 24, 2025
As we come to the end of the year, we would like to wish everyone a very Happy Christmas and a healthy, successful New Year. 2025 has been a hugely rewarding year for the Pharmidex team. We’re proud to have supported close to 1,000 projects, working alongside innovative companies across pharma and biotech to help advance new ideas, technologies, and programmes. Thank you to our clients, collaborators, and partners for trusting us to be part of your journey. We look forward to continuing to support even more projects and working together in the year ahead. From everyone at Pharmidex , Merry Christmas and see you in the New Year! ๐ŸŽ„โœจ
More Posts